The Melino teams demonstrated that p63 might inhibit metastasis by its ability to interact with p53 [41], and specifically in prostate cancer through the regulation of miR-205; this miR being essential for the inhibitory effects of p63 on markers of the EMT [42]. The gene discussed is TP53; the disease is prostate carcinoma.